Novamed

Africa

Novamed, Ltd is a leader in the development, manufacturing, and marketing of products used for diagnosing infectious diseases.

We are invested in Novamed through EuroMena III, which is managed by EuroMena. For further information on the fund, the fund manager, and the expected impact of the fund’s investment, click here.

Key facts

Status:
Active
Region

Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.

:
Africa
Investment type

We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).

:
Intermediated investment
Fund:
EuroMena III
Fund Manager:
EuroMena
Start date

For direct investments, this is the date CDC committed capital to the business or project.

For funds, this is the date that CDC committed capital to the fund.

For underlying fund investments, this is the date that the fund invested capital into the business.e

:
February 2019
Domicile

This is the investee company’s place of incorporation; or a fund’s jurisdiction.

:
Cote D'Ivoire